1. Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-alpha and IL-6 production, ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS. 2. Atractylenolide-I significantly sensitizes the response of MyD88(+) EOC cells to paclitaxel by blocking MD-2-mediated TLR4/MyD88 signaling.
Molekulargewicht:
230.3
Reinheit:
97.55%
CAS Nummer:
[73069-13-3]
Formel:
C15H18O2
Target-Kategorie:
IL Receptor|||TNF|||TLR|||JAK|||STAT
T5S0167
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten